Skip to main content

Animations

MJFF Publications

3001 - 3010 of 6570 Results
Title
Year
  • Year
  • 2011
  • 2013
  • 2012
  • 2014
  • 2017
  • 2010
  • 2009
  • 2009
  • 2013
  • 2013
  • Summary Details
    OPEN
    Title: Hyperphosphorylated Tau in an α-synuclein-overexpressing transgenic model of Parkinson’s disease
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1460-9568.2011.07660.x
    Citation Count: 124
  • Summary Details
    OPEN
    Title: Pesticides that inhibit the ubiquitin–proteasome system: Effect measure modification by genetic variation in SKP1 in Parkinson׳s disease
    Journal Name: Environmental Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.envres.2013.08.001
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Serotonin transporter inhibition attenuatesl‐DOPA‐induced dyskinesia without compromisingl‐DOPA efficacy in hemi‐parkinsonian rats
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/j.1460-9568.2012.08202.x
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Mind matters: placebo enhances reward learning in Parkinson's disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3842
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI
    Journal Name: Nature Protocols
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nprot.2017.081
    Citation Count: 183
  • Summary Details
    OPEN
    Title: Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.642
    Citation Count: 816
  • Summary Details
    OPEN
    Title: α-Synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/ng.300
    Best OA location URL: http://doi.org/10.1038/ng.300
    Citation Count: 538
  • Summary Details
    OPEN
    Title: Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.2349
    Best OA location URL: http://doi.org/10.1038/nn.2349
    Citation Count: 540
  • Summary Details
    OPEN
    Title: A causal link between prediction errors, dopamine neurons and learning
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3413
    Citation Count: 943
  • Summary Details
    OPEN
    Title: CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nn.3353
    Citation Count: 82
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.